Interestingly, analysis of synaptoneurosomes from AD patients revealed a ~2-fold increase in EphA4 mRNA [32], suggesting a role in synaptotoxicity for EphA4 Therefore we investigated EphA4 expression and localization in the hippocampus of patients at various Braak stages. This evidence concerns the gene EPHA4 and Alzheimer disease.